Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: PENMT (Experimental Group)
Total 0 results
Nothing found
Sponsors and Collaborators
Remedy Institute
Health Holding Company, Hail Health Cluster, Saudi Arabia
Méthodologie et Evaluation pour la Recherche clinique et Epidémiologique sur le VIH en Afrique (MEREVA)
Resurge Therapeutics Inc.
Paul W. Read, MD
Kettering Foundation
Sonogenix
Brigham and Womens' Hospital, Center for Surgery and Public Health
NATURAmedicatrix Sàrl
Australian Childhood Foundation
Sociedad Española de Arteriosclerosis
The Depressive and Bipolar Disorder Alternative Treatment Foundation
Zhijun Sun
Laboratoires Iprad-Vegebom
Prader-Willi Syndrome Association of Australia
Dr Gilles DUCHEIX/ Center of clinical pharmacology/CIC Inserm-501 - Investigator
wenbinlu
Jain, Isha, B.A., Massachusetts General Hospital, Harvard Medical School
Epicentre, Paris, France.
Carlos III Health Institute
View Full List
Medical Conditions
Escape Room Games and Role Playing Gamification
Cell Senescence
Malignant Tumor of Extrahepatic Bile Duct
Spinocerebellar Ataxia Genotype Type 3
Hernia,Ventral
Pregnancy; Accident
Ankle Trauma
Stroke Recrudescence
Lymphoblastic Lymphoma
Refractory B-Lineage Lymphoma
Mycobacterium Avium Complex Infections
Neurobehavioral Manifestation
Stage III Childhood Anaplastic Large Cell Lymphoma
Adherence to In-Office Glaucoma Evaluation Appointment
Stage IIIB Esophageal Adenocarcinoma
Apneic; Oxygenation
Marginal Zone B-cell Lymphoma
Intervention Studies
Psychoactive Substance Use
Relapsed/Refractory Diffuse Large B-cell Lymphoma
View Full List
Drug Interventions
Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
ART-123
LINjeta U-100 Insulin
Gadoteridol (ProHance)
Fenofibric acid 135mg
FRSW107
Epalrestat
Omeprazole 40 mg
SBI-087
300 mg of caffeine citrate infusion
Everolimus
Oral Aztreonam
Fortum (Ceftazidime for injection USP) Glaxo Smith Kline Pharmaceuticals Limited
Colecalciferol D3 (Vigantol Oil)
Triple therapy
Low molecular weight Heparin as standard of care treatment
Optiva artificial tear by Allergan
Lansoprazole 15mg QD
Irinotecan
Fostamatinib
View Full List
CROs by country
Contract Research Organizations in Armenia
Contract Research Organizations in Azerbaijan
Contract Research Organizations in Gambia
Contract Research Organizations in Hungary
Contract Research Organizations in Latvia
Contract Research Organizations in Mongolia
Contract Research Organizations in Pakistan
Contract Research Organizations in Papua New Guinea
Contract Research Organizations in Portugal
Contract Research Organizations in Russia
Contract Research Organizations in Saudi Arabia
Contract Research Organizations in Switzerland
Contract Research Organizations in United Kingdom
CRO list by country
CROs in Finland
Smerud Medical Research Group
Rede Optimus Hopitalar AG
Charles River Laboratories
ProPharma Group
Parexel
LINK Medical
IRW Consulting
Dokumeds
Crown CRO
IQVIA
All CROs in Finland
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe